Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma

Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Interventions: Drug: Sintilimab+Pegaspargase; Drug: P-GemOx; Drug: GELAD; Radiation: IMRT Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials